Malaria

The first vaccine of its kind could be rolled out to billions worldwide after advisers gave it the green light.

BioNTech, which worked with Pfizer on the coronavirus jab, is aiming to begin clinical trials for a "safe and highly effective malaria vaccine".

Malaria parasites, which are drug-resistant, have spread rapidly across South East Asia, according to UK and Thailand researchers.